These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 8453696

  • 1. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ, Agarwal K, Zornig C, Schwarz R, Dietel M, Hossfeld DK.
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [Abstract] [Full Text] [Related]

  • 2. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH.
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas.
    Comandone A, Bretti S, Bertetto O, Oliva C, Bergnolo P, Bumma C.
    Anticancer Res; 2000 Dec; 20(3B):2077-80. PubMed ID: 10928155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, Gebhardt M, Pratt C, Grier HE.
    J Clin Oncol; 2005 Jun 20; 23(18):4031-8. PubMed ID: 15767644
    [Abstract] [Full Text] [Related]

  • 9. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J, Fra J, López-Pousa A, García del Muro X, Balañá C, Casado A, Martín J, Martínez-Trufero J, de las Peñas R, Buesa JM, Spanish Group for Research on Sarcomas (GEIS).
    Cancer; 2004 Apr 01; 100(7):1498-506. PubMed ID: 15042685
    [Abstract] [Full Text] [Related]

  • 10. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J, Kellner R, Seeber S.
    Cancer Chemother Pharmacol; 1993 Apr 01; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH, Wen XP, Hu L.
    Ai Zheng; 2002 Aug 01; 21(8):907-9. PubMed ID: 12478905
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
    Pápai Z, Bodoky G, Szántó J, Poller I, Rahóty P, Eckhardt S, Láng I, Szendroi M.
    Cancer; 2000 Jul 01; 89(1):177-80. PubMed ID: 10897015
    [Abstract] [Full Text] [Related]

  • 14. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT, Metch B, Weiss SA, Weick JK, Fabian C, Stephens RL, Balcerzak SP.
    Cancer Chemother Pharmacol; 1993 Jul 01; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [Abstract] [Full Text] [Related]

  • 15. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT, European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Lancet Oncol; 2014 Apr 01; 15(4):415-23. PubMed ID: 24618336
    [Abstract] [Full Text] [Related]

  • 16. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX, Zhang YT, Shang JT, Xu Z, Geng Y, Li SM, Shi F, Wu YY.
    Ai Zheng; 2006 Aug 01; 25(8):1048-51. PubMed ID: 16965692
    [Abstract] [Full Text] [Related]

  • 17. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R, Dalley D, Bell DR, Levi J, Simes RJ, Wiltshaw E.
    Cancer Chemother Pharmacol; 1993 Aug 01; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [Abstract] [Full Text] [Related]

  • 18. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
    Barişta I, Tekuzman G, Yalçin S, Güllü I, Güler N, Ozişik Y, Kars A, Celik I, Türker A, Altundağ K, Zengin N, Uner A, Baltali E, Firat D.
    J Surg Oncol; 2000 Jan 01; 73(1):12-6. PubMed ID: 10649272
    [Abstract] [Full Text] [Related]

  • 19. Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
    Patsner B, Greenberg S.
    Gynecol Oncol; 1995 Sep 01; 58(3):386-8. PubMed ID: 7672707
    [Abstract] [Full Text] [Related]

  • 20. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD, Elias AD.
    Hematol Oncol Clin North Am; 1995 Aug 01; 9(4):765-85. PubMed ID: 7490240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.